2nd Advanced Course on the Pharmacological Treatment of Drug Resistant Epilepsies: From Rare to Common Epilepsies
Dear colleagues,
It is our pleasure to announce the "2nd Advanced Course on the Pharmacological Treatment of Drug Resistant Epilepsies: From Rare to Common Epilepsies" that will take place in Palma de Mallorca from November 8 to 10, 2024.
The objective of the course is to offer an update on current and future pharmacological treatments and strategies for drug-resistant epilepsies. The target audience is physicians and basic scientists willing to increase their knowledge on how to improve the treatment of these most challenging epilepsies. The audience will be encouraged to actively participate through case discussions.
The island of Mallorca and the city of Palma de Mallorca are an amazing frame that will surely enhance interaction between alumni and teachers during this 3-day course.
We look forward to seeing you soon in Mallorca!
The course directors,
Dr. Jose M Serratosa Fernández. Epilepsy Unit and Department of Neurology. Fundación Jiménez Díaz University Hospital. Madrid, Spain
Dr. Bernhard J Steinhoff. Professor of Neurology and Clinical Neurophysiology, University of Freiburg; Medical Director, Kork Epilepsy Center, Kehl-Kork, Germany
Dr. Manuel Toledo Argany. Director, Epilepsy Unit. Vall d'Hebrón University Hospital. Barcelona, Spain
Dr. Torbjörn Tomson. Senior Professor of Neurology and Epileptology, Department of Clinical Neuroscience, Karolinska Institutet. Sweden
It is our pleasure to announce the "2nd Advanced Course on the Pharmacological Treatment of Drug-Resistant Epilepsies: From Rare to Common Epilepsies" that will take place in Palma de Mallorca from November 8 to 10, 2024.
The objective of the course is to offer an update on current and future pharmacological treatments and strategies for drug-resistant epilepsies. The target audience is physicians and basic scientists willing to increase their knowledge on how to improve the treatment of these most challenging epilepsies. The audience will be encouraged to actively participate in case discussions.
To register, click here.